COMMUNIQUÉ DE PRESSE publié le 08/07/2024 à 16:30, il y a 2 années 1 mois Issuance of New European & Australian Patents Bolster IP Protection for Jaguar Health in the Treatment of Short Bowel Syndrome (SBS) and Congenital Diarrheal Disorders (CDDs) New patents issued for core rare disease target indications for crofelemer. Jaguar Health announces new patents from European Patent Office and IP Australia for Napo Pharmaceuticals' crofelemer. Expected results in 2024 and 2025 Napo Pharmaceuticals Crofelemer Jaguar Health Patents Rare Disease
Publié le 29/08/2026 à 05:15, il y a 1 jour 10 heures Norsemont Announces Restatement of Financial Statements
Publié le 29/08/2026 à 03:20, il y a 1 jour 12 heures BEACN Announces Financial Results for the Second Quarter of 2026
Publié le 29/08/2026 à 01:15, il y a 1 jour 14 heures Gamma Resources Announces Increase in Private Placement to $1,750,000 and Closing of First Tranche at $872,500
Publié le 29/08/2026 à 01:00, il y a 1 jour 14 heures Lobe Sciences Ltd. Announces Upsize to Non-Brokered Private Placement
Publié le 28/08/2026 à 23:00, il y a 1 jour 16 heures Guanajuato Silver Grants Stock Options to Officer
Publié le 29/08/2026 à 04:05, il y a 1 jour 11 heures INTCO Medical Reports 40.6% H1 2026 Revenue Growth, Expands World's Largest Disposable Glove Capacity to 107 Billion Pieces
Publié le 28/08/2026 à 20:49, il y a 1 jour 19 heures Publication pursuant to Article 5(1)(b) and (3) of Regulation (EU) No. 596/2014 and Article 2(2) and (3) of the Commission Delegated Regulation (EU) No. 2016/1052 - Final Announcement
Publié le 28/08/2026 à 20:42, il y a 1 jour 19 heures Aroundtown SA: Release of a capital market information
Publié le 28/08/2026 à 19:10, il y a 1 jour 20 heures Invitation to Professional or Qualified Investors holding Notes to submit offers for Branicks Bridge Notes and VIB Bridge Notes
Publié le 28/08/2026 à 18:01, il y a 1 jour 21 heures CPI Europe announces unaudited results for the first half of 2026
